Cargando…
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma
Autores principales: | Di Marco, Lorenza, Pivetti, Alessandra, Foschi, Francesco Giuseppe, D’Amico, Roberto, Schepis, Filippo, Caporali, Cristian, Casari, Federico, Lasagni, Simone, Critelli, Rosina Maria, Milosa, Fabiola, Romanzi, Adriana, Marcelli, Gemma, De Maria, Nicola, Romagnoli, Dante, Catellani, Barbara, Scianò, Filippo, Magistri, Paolo, Colecchia, Antonio, Sighinolfi, Pamela, Di Benedetto, Fabrizio, Martinez-Chantar, Maria-Luz, Villa, Erica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106106/ https://www.ncbi.nlm.nih.gov/pubmed/36747351 http://dx.doi.org/10.1097/LVT.0000000000000087 |
Ejemplares similares
-
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma
por: Critelli, Rosina Maria, et al.
Publicado: (2022) -
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation
por: Lasagni, Simone, et al.
Publicado: (2022) -
Obese zebrafish: A small fish for a major human health condition
por: Faillaci, Francesca, et al.
Publicado: (2018) -
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study
por: Critelli, Rosina, et al.
Publicado: (2017) -
Liver Angiopoietin‐2 Is a Key Predictor of D
e
N
ovo or Recurrent Hepatocellular Cancer After Hepatitis C
Virus Direct‐Acting Antivirals
por: Faillaci, Francesca, et al.
Publicado: (2018)